Does COVID-19 Pandemic Reduce In-hospital Mortality?

NCT04480515 | Completed

• 1 other identifier: KSSEAH--IHM
• Study Type: observational
• Target: 5,000
• Locations: 1 country
• Sites: 1

Brief Summary

COVID-19, which emerged in China in December 2019, has become a pandemic with its spread to many countries of the world. Although it is suggested that hospital admissions are reduced due to some reasons such as trauma, during COVID-19 pandemic, it is controversial whether in-hospital mortality rates changed. Therefore this multi-centered study aimed to determine how in-hospital mortality effected during the pandemic period according to the specific patient groups.

Conditions

Covid19; In-hospital Cardiac Arrest

Outcome Measures

Primary Outcomes (1)

• In-hospital mortality

  During the pandemic (March-July), deaths occurred in hospital will be evaluated.

  4 months

Interventions

in-hospital mortality rate OTHER

In-hospital mortality rate during pandemic of 2020 will be compared with the in-hospital mortality rate of the last year's same time period

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

All the records of in-hospital mortality will be evaluated

You may qualify if:

• Deaths, with all required data available, occurred within the study hospitals
• centers Accepted to participate with an informed consent

You may not qualify if:

• lack of consent
• lack of data
• deaths occurred outside the study hospitals

Sponsors & Collaborators

• Kanuni Sultan Suleyman Training and Research Hospital: lead

Study Sites (1)

Kanuni Sultan Suleyman Training and Research Hospital

Istanbul, 34303, Turkey (Türkiye)

Location

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: OTHER
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Professor

Study Record Dates

• First Submitted: July 17, 2020
• First Posted: July 21, 2020
• Study Start: March 11, 2020
• Primary Completion: June 15, 2020
• Study Completion: June 30, 2020
• Last Updated: July 21, 2020

Record last verified: 2020-07

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)